Product Code: TMRGL11096
TMR's report on the global vascular grafts market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global vascular grafts market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vascular grafts market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vascular grafts market.
The report delves into the competitive landscape of the global vascular grafts market. Key players operating in the global vascular grafts market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global vascular grafts market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vascular Grafts Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Vascular Grafts Market Analysis and Forecast, 2017-2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Global Prevalence of Chronic Kidney Diseases
- 5.3. Global Prevalence of Cardiovascular Diseases
- 5.4. Covid-19 Pandemic Impact on the Industry
6. Global Vascular Grafts Market Analysis and Forecast, by Product
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product, 2017-2031
- 6.3.1. Endovascular Stent Graft
- 6.3.2. Peripheral Vascular Graft
- 6.3.3. Hemodialysis Access Graft
- 6.3.4. Bypass Graft
- 6.3.5. Others
- 6.4. Market Attractiveness Analysis, by Product
7. Global Vascular Grafts Market Analysis and Forecast, by Size of Vascular Graft
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 7.3.1. Large Size Vascular Graft
- 7.3.2. Small Size Vascular Graft
- 7.4. Market Attractiveness Analysis, by Size of Vascular Graft
8. Global Vascular Grafts Market Analysis and Forecast, by Source
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Source, 2017-2031
- 8.3.1. Synthetic
- 8.3.1.1. Polytetrafluethylene (PTFE)
- 8.3.1.2. Polyurethane (PU)
- 8.3.1.3. Dacron
- 8.3.1.4. Others
- 8.3.2. Biological
- 8.3.2.1. Bovine Vein
- 8.3.2.2. Saphenous Vein
- 8.3.2.3. Others
- 8.3.3. Biosynthetic
- 8.3.3.1. Ovine Collagen with Polyester
- 8.3.3.2. Others
- 8.4. Market Attractiveness Analysis, by Source
9. Global Vascular Grafts Market Analysis and Forecast, by Application
- 9.1. Introduction & Definition
- 9.2. Key Findings / Developments
- 9.3. Market Value Forecast, by Application, 2017-2031
- 9.3.1. Coronary Artery Bypass
- 9.3.2. Aneurysm
- 9.3.3. Vascular Occlusion
- 9.3.4. Critical Limb Ischemia
- 9.3.5. Renal Failure
- 9.3.6. Others
- 9.4. Market Attractiveness Analysis, by Application
10. Global Vascular Grafts Market Analysis and Forecast, by End-user
- 10.1. Introduction & Definition
- 10.2. Key Findings / Developments
- 10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals
- 10.3.2. Ambulatory Surgery Centers
- 10.3.3. Cardiac Catheterization Laboratories
- 10.3.4. Specialty Clinics
- 10.3.5. Others
- 10.4. Market Attractiveness Analysis, by End-user
11. Global Vascular Grafts Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness Analysis, by Region
12. North America Vascular Grafts Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product, 2017-2031
- 12.2.1. Endovascular Stent Graft
- 12.2.2. Peripheral Vascular Graft
- 12.2.3. Hemodialysis Access Graft
- 12.2.4. Bypass Graft
- 12.2.5. Others
- 12.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 12.3.1. Large Size Vascular Graft
- 12.3.2. Small Size Vascular Graft
- 12.4. Market Value Forecast, by Source, 2017-2031
- 12.4.1. Synthetic
- 12.4.1.1. Polytetrafluethylene (PTFE)
- 12.4.1.2. Polyurethane (PU)
- 12.4.1.3. Dacron
- 12.4.1.4. Others
- 12.4.2. Biological
- 12.4.2.1. Bovine Vein
- 12.4.2.2. Saphenous Vein
- 12.4.2.3. Others
- 12.4.3. Biosynthetic
- 12.4.3.1. Ovine Collagen with Polyester
- 12.4.3.2. Others
- 12.5. Market Value Forecast, by Application , 2017-2031
- 12.5.1. Coronary Artery Bypass
- 12.5.2. Aneurysm
- 12.5.3. Vascular Occlusion
- 12.5.4. Critical Limb Ischemia
- 12.5.5. Renal Failure
- 12.5.6. Others
- 12.6. Market Value Forecast, by End-user, 2017-2031
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Surgery Centers
- 12.6.3. Cardiac Catheterization Laboratories
- 12.6.4. Specialty Clinics
- 12.6.5. Others
- 12.7. Market Value Forecast, by Country, 2017-2031
- 12.7.1. U.S.
- 12.7.2. Canada
- 12.8. Market Attractiveness Analysis
- 12.8.1. By Product
- 12.8.2. By Size of Vascular Graft
- 12.8.3. By Source
- 12.8.4. By Application
- 12.8.5. By End-user
- 12.8.6. By Country
13. Europe Vascular Grafts Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product, 2017-2031
- 13.2.1. Endovascular Stent Graft
- 13.2.2. Peripheral Vascular Graft
- 13.2.3. Hemodialysis Access Graft
- 13.2.4. Bypass Graft
- 13.2.5. Others
- 13.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 13.3.1. Large Size Vascular Graft
- 13.3.2. Small Size Vascular Graft
- 13.4. Market Value Forecast, by Source, 2017-2031
- 13.4.1. Synthetic
- 13.4.1.1. Polytetrafluethylene (PTFE)
- 13.4.1.2. Polyurethane (PU)
- 13.4.1.3. Dacron
- 13.4.1.4. Others
- 13.4.2. Biological
- 13.4.2.1. Bovine Vein
- 13.4.2.2. Saphenous Vein
- 13.4.2.3. Others
- 13.4.3. Biosynthetic
- 13.4.3.1. Ovine Collagen with Polyester
- 13.4.3.2. Others
- 13.5. Market Value Forecast, by Application, 2017-2031
- 13.5.1. Coronary Artery Bypass
- 13.5.2. Aneurysm
- 13.5.3. Vascular Occlusion
- 13.5.4. Critical Limb Ischemia
- 13.5.5. Renal Failure
- 13.5.6. Others
- 13.6. Market Value Forecast, by End-user, 2017-2031
- 13.6.1. Hospitals
- 13.6.2. Ambulatory Surgery Centers
- 13.6.3. Cardiac Catheterization Laboratories
- 13.6.4. Specialty Clinics
- 13.6.5. Others
- 13.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.7.1. Germany
- 13.7.2. U.K.
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. Rest of Europe
- 13.8. Market Attractiveness Analysis
- 13.8.1. By Product
- 13.8.2. By Size of Vascular Graft
- 13.8.3. By Source
- 13.8.4. By Application
- 13.8.5. By End-user
- 13.8.6. By Country/Sub-region
14. Asia Pacific Vascular Grafts Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product, 2017-2031
- 14.2.1. Endovascular Stent Graft
- 14.2.2. Peripheral Vascular Graft
- 14.2.3. Hemodialysis Access Graft
- 14.2.4. Bypass Graft
- 14.2.5. Others
- 14.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 14.3.1. Large Size Vascular Graft
- 14.3.2. Small Size Vascular Graft
- 14.4. Market Value Forecast, by Source, 2017-2031
- 14.4.1. Synthetic
- 14.4.1.1. Polytetrafluethylene (PTFE)
- 14.4.1.2. Polyurethane (PU)
- 14.4.1.3. Dacron
- 14.4.1.4. Others
- 14.4.2. Biological
- 14.4.2.1. Bovine Vein
- 14.4.2.2. Saphenous Vein
- 14.4.2.3. Others
- 14.4.3. Biosynthetic
- 14.4.3.1. Ovine Collagen with Polyester
- 14.4.3.2. Others
- 14.5. Market Value Forecast, by Application, 2017-2031
- 14.5.1. Coronary Artery Bypass
- 14.5.2. Aneurysm
- 14.5.3. Vascular Occlusion
- 14.5.4. Critical Limb Ischemia
- 14.5.5. Renal Failure
- 14.5.6. Others
- 14.6. Market Value Forecast, by End-user, 2017-2031
- 14.6.1. Hospitals
- 14.6.2. Ambulatory Surgery Centers
- 14.6.3. Cardiac Catheterization Laboratories
- 14.6.4. Specialty Clinics
- 14.6.5. Others
- 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. Rest of Asia Pacific
- 14.8. Market Attractiveness Analysis
- 14.8.1. By Product
- 14.8.2. By Size of Vascular Graft
- 14.8.3. By Source
- 14.8.4. By Application
- 14.8.5. By End-user
- 14.8.6. By Country/Sub-region
15. Latin America Vascular Grafts Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Product, 2017-2031
- 15.2.1. Endovascular Stent Graft
- 15.2.2. Peripheral Vascular Graft
- 15.2.3. Hemodialysis Access Graft
- 15.2.4. Bypass Graft
- 15.2.5. Others
- 15.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 15.3.1. Large Size Vascular Graft
- 15.3.2. Small Size Vascular Graft
- 15.4. Market Value Forecast, by Source, 2017-2031
- 15.4.1. Synthetic
- 15.4.1.1. Polytetrafluethylene (PTFE)
- 15.4.1.2. Polyurethane (PU)
- 15.4.1.3. Dacron
- 15.4.1.4. Others
- 15.4.2. Biological
- 15.4.2.1. Bovine Vein
- 15.4.2.2. Saphenous Vein
- 15.4.2.3. Others
- 15.4.3. Biosynthetic
- 15.4.3.1. Ovine Collagen with Polyester
- 15.4.3.2. Others
- 15.5. Market Value Forecast, by Application , 2017-2031
- 15.5.1. Coronary Artery Bypass
- 15.5.2. Aneurysm
- 15.5.3. Vascular Occlusion
- 15.5.4. Critical Limb Ischemia
- 15.5.5. Renal Failure
- 15.5.6. Others
- 15.6. Market Value Forecast, by End-user, 2017-2031
- 15.6.1. Hospitals
- 15.6.2. Ambulatory Surgery Centers
- 15.6.3. Cardiac Catheterization Laboratories
- 15.6.4. Specialty Clinics
- 15.6.5. Others
- 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Rest of Latin America
- 15.8. Market Attractiveness Analysis
- 15.8.1. By Product
- 15.8.2. By Size of Vascular Graft
- 15.8.3. By Source
- 15.8.4. By Application
- 15.8.5. By End-user
- 15.8.6. By Country/Sub-region
16. Middle East & Africa Vascular Grafts Market Analysis and Forecast
- 16.1. Introduction
- 16.2. Market Value Forecast, by Product, 2017-2031
- 16.2.1. Endovascular Stent Graft
- 16.2.2. Peripheral Vascular Graft
- 16.2.3. Hemodialysis Access Graft
- 16.2.4. Bypass Graft
- 16.2.5. Others
- 16.3. Market Value Forecast, by Size of Vascular Graft, 2017-2031
- 16.3.1. Large Size Vascular Graft
- 16.3.2. Small Size Vascular Graft
- 16.4. Market Value Forecast, by Source, 2017-2031
- 16.4.1. Synthetic
- 16.4.1.1. Polytetrafluethylene (PTFE)
- 16.4.1.2. Polyurethane (PU)
- 16.4.1.3. Dacron
- 16.4.1.4. Others
- 16.4.2. Biological
- 16.4.2.1. Bovine Vein
- 16.4.2.2. Saphenous Vein
- 16.4.2.3. Others
- 16.4.3. Biosynthetic
- 16.4.3.1. Ovine Collagen with Polyester
- 16.4.3.2. Others
- 16.5. Market Value Forecast, by Application, 2017-2031
- 16.5.1. Coronary Artery Bypass
- 16.5.2. Aneurysm
- 16.5.3. Vascular Occlusion
- 16.5.4. Critical Limb Ischemia
- 16.5.5. Renal Failure
- 16.5.6. Others
- 16.6. Market Value Forecast, by End-user, 2017-2031
- 16.6.1. Hospitals
- 16.6.2. Ambulatory Surgery Centers
- 16.6.3. Cardiac Catheterization Laboratories
- 16.6.4. Specialty Clinics
- 16.6.5. Others
- 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
- 16.8. Market Attractiveness Analysis
- 16.8.1. By Product
- 16.8.2. By Size of Vascular Graft
- 16.8.3. By Source
- 16.8.4. By Application
- 16.8.5. By End-user
- 16.8.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (by tier and size of companies)
- 17.2. Market Share Analysis, by Company, 2021
- 17.3. Company Profiles
- 17.3.1. B. Braun SE
- 17.3.1.1. Company Overview
- 17.3.1.2. Product Portfolio
- 17.3.1.3. SWOT Analysis
- 17.3.1.4. Strategic Overview
- 17.3.2. BD
- 17.3.2.1. Company Overview
- 17.3.2.2. Product Portfolio
- 17.3.2.3. SWOT Analysis
- 17.3.2.4. Strategic Overview
- 17.3.3. Cook Medical, Inc.
- 17.3.3.1. Company Overview
- 17.3.3.2. Product Portfolio
- 17.3.3.3. SWOT Analysis
- 17.3.3.4. Strategic Overview
- 17.3.4. CryoLife, Inc.
- 17.3.4.1. Company Overview
- 17.3.4.2. Product Portfolio
- 17.3.4.3. SWOT Analysis
- 17.3.4.4. Strategic Overview
- 17.3.5. Getinge AB
- 17.3.5.1. Company Overview
- 17.3.5.2. Product Portfolio
- 17.3.5.3. SWOT Analysis
- 17.3.5.4. Strategic Overview
- 17.3.6. Heart Medical
- 17.3.6.1. Company Overview
- 17.3.6.2. Product Portfolio
- 17.3.6.3. SWOT Analysis
- 17.3.6.4. Strategic Overview
- 17.3.7. JUNKEN MEDICAL Co., Ltd.
- 17.3.7.1. Company Overview
- 17.3.7.2. Product Portfolio
- 17.3.7.3. SWOT Analysis
- 17.3.7.4. Strategic Overview
- 17.3.8. LeMaitre Vascular, Inc.
- 17.3.8.1. Company Overview
- 17.3.8.2. Product Portfolio
- 17.3.8.3. SWOT Analysis
- 17.3.8.4. Strategic Overview
- 17.3.9. Medtronic
- 17.3.9.1. Company Overview
- 17.3.9.2. Product Portfolio
- 17.3.9.3. SWOT Analysis
- 17.3.9.4. Strategic Overview
- 17.3.10. Terumo Corporation
- 17.3.10.1. Company Overview
- 17.3.10.2. Product Portfolio
- 17.3.10.3. SWOT Analysis
- 17.3.10.4. Strategic Overview
- 17.3.11. Vascular Graft Solutions
- 17.3.11.1. Company Overview
- 17.3.11.2. Product Portfolio
- 17.3.11.3. SWOT Analysis
- 17.3.11.4. Strategic Overview
- 17.3.12. W. L. Gore & Associates, Inc.
- 17.3.12.1. Company Overview
- 17.3.12.2. Product Portfolio
- 17.3.12.3. SWOT Analysis
- 17.3.12.4. Strategic Overview